I like INO, but don't like the share price performance YTD. It's in the red. (Do the math.)
I also like ONCS, just more so in the short-term. It's up over 100% YTD and will be surging higher through EOY and into next year. More short-term catalysts than INO, that's all. INO is great longer-term.
In the spirit of "what have you done for me lately," what did INO do today? What did ONCS do today? What percent difference is that? More like that in the coming days ahead...
Again, to make my position perfectly clear. INO is a great long-term investment. Short-term, not so much.
For sure. I have an open mind.
I just try to "follow the money," and in the short-term more roads lead to ONCS than INO. That's all.
ONLY respond to them if the subject title has a positive connotation for ONCS.
That way, it will be brought to the top and any "sane" person who takes the time to read into the thread will easily see that forarmy1 is a useless troll with an agenda. The truth will boil to the top as long as the subject heading is such.
Lots of INO investors have already made the switch. That's part of the reason ONCS is surging.
INO will be a better investment early next year, after the share price has bottomed out and some of the catalysts are closer to fruition.
You're preaching to the choir here, Dean. INO is a good long-term investment. It all depends on one's "time horizon" for making significant returns. Your mileage may vary.
However, I still maintain that ONCS is a better investment NOW and in the foreseeable future than INO based on future prospects and its current market cap.
If you disagree with this, fine, no worries. But I would like to understand "why" you disagree.
Look at the YTD performance. It's simple math.
INO is in negative territory, and ONCS is up over 100%.
It's simple math, folks! Do it!
That's great that you got in early. That's where to expect the greatest gains. That's what I've done with ONCS. The key is getting in early.
INO is in NEGATIVE territory both for YTD and post-RS valuation. Most people who bought this year are under water. That's not to say it won't perform well in 2015. But 2014 was certainly a forgettable year as far as share price appreciation. Not the "dwarfing" that Dr. Kim promised.
Again, the key is getting in early. That's the opportunity with ONCS and why it's trading up today instead of down with the rest of the market. I suspect INO will continue to trend downward, but will be a good buy early next year.
INO is a great company, but "loving" a stock won't make you any money. How has INO performed YTD? What was it selling for on 1/2/2014?
Do the math.
What has INO done for us lately? It's DOWN since the RS. I've seen you post here many times and I know you're smart enough to do the math.
INO is a great long-term investment. Short-term? Not so much. ONCS is much better and my brokerage account value reflects that.
It depends on when one purchased shares. Buy low, sell high. :)
What about YTD numbers? It was selling for 11.48 on 1/2/2014.
That's a negative return for the calendar year 2014. Not exactly dwarfing?
Glad to see you over here, xcellprouk.
Further validation that ONCS is on the right track and winning the fight to defeat cancer.
I enjoy working, but if this thing does what I believe it will do during the next year, I'll be in early retirement. No problem.
You, sir, are a direct manifestation of all that is EVIL in the world.
You need to be banned for life from ALL social media.
Do a search on it at the top of your screen.